Purdue Pharma and Sackler Family Reach $7.4 Billion Settlement Over Opioid Crisis
Purdue Pharma and Sackler family agree to a $7.4 billion settlement to address opioid crisis lawsuits, subject to court approval.
Subscribe to unlock this story
We really don't like cutting you off, but you've reached your monthly limit. At just $5/month, subscriptions are how we keep this project going. Start your free 7-day trial today!
Get Started
The substantial $7 billion settlement with Purdue Pharma represents a significant step toward holding those responsible for the opioid crisis accountable, but it remains to be seen if this will truly bring about the lasting change and healing communities desperately need.
Sackler, Purdue Pharma $7 billion lawsuit: Who's entitled to payment
Newsweek·3M·Mostly ReliableThis source is generally reliable but sometimes includes opinion, propaganda, or minor inaccuracies.CenterThis outlet is balanced or reflects centrist views.
This landmark settlement, if approved, signifies a crucial step towards accountability for the Sackler family and Purdue Pharma in the ongoing battle against the opioid crisis.
Purdue Pharma, Sacklers reach new settlement agreement in opioid cases
The Hill·3M·ReliableThis source consistently reports facts with minimal bias, demonstrating high-quality journalism and accuracy.CenterThis outlet is balanced or reflects centrist views.
The newly agreed settlement stands as a significant step towards addressing the financial fallout from the opioid crisis, promising billions for victim compensation and public health measures, albeit with a backdrop of continued scrutiny on the Sackler family's responsibilities.
Purdue Pharma, Sacklers to pay $7.4bn in new opioid settlement
Al Jazeera·3M·ReliableThis source consistently reports facts with minimal bias, demonstrating high-quality journalism and accuracy.Leans LeftThis outlet slightly leans left.
The agreement to settle claims against Purdue Pharma and the Sackler family marks a pivotal moment in the ongoing battle against the opioid crisis, aiming to deliver much-needed resources to address addiction treatment and prevention.
Purdue and Sackler family agree $7.4bn OxyContin settlement
BBC News·3M·ReliableThis source consistently reports facts with minimal bias, demonstrating high-quality journalism and accuracy.CenterThis outlet is balanced or reflects centrist views.
The new settlement, while significant in its financial scope, does little to hold the Sackler family accountable for their role in the opioid crisis, which has wreaked havoc on countless lives.
Purdue Pharma and Sackler family to pay $7.4 billion in settlement to OxyContin lawsuits
NBC News·3M·ReliableThis source consistently reports facts with minimal bias, demonstrating high-quality journalism and accuracy.CenterThis outlet is balanced or reflects centrist views.
The Sackler family’s long-standing control over Purdue Pharma has finally come to an end, a crucial step in seeking accountability for their role in perpetuating the opioid crisis that has devastated countless lives.
Sackler family, Purdue Pharma reach $7.4 billion settlement with 15 states over opioid crisis
CBS News·3M·ReliableThis source consistently reports facts with minimal bias, demonstrating high-quality journalism and accuracy.CenterThis outlet is balanced or reflects centrist views.
The new settlement represents a crucial step in addressing the devastation caused by the opioid crisis, although it also highlights the ongoing challenges of accountability for manufacturers like Purdue Pharma and the Sackler family.
Purdue Pharma, Sacklers reach $7.4 billion national opioid settlement
CNBC·3M·ReliableThis source consistently reports facts with minimal bias, demonstrating high-quality journalism and accuracy.CenterThis outlet is balanced or reflects centrist views.
The Sackler family's agreement to a $7.4 billion settlement is a significant step towards accountability for a dynasty that has long evaded repercussions for its role in the opioid crisis.
Purdue Pharma and Sacklers reach new $7.4bn settlement over opioids crisis
The Guardian·3M·ReliableThis source consistently reports facts with minimal bias, demonstrating high-quality journalism and accuracy.Leans LeftThis outlet slightly leans left.
The new settlement marks a crucial step towards addressing the devastating opioid crisis, highlighting the necessity for accountability from pharmaceutical companies and the pivotal role these funds will play in providing restitution and support for victims.
Purdue Pharma and owners to pay $7.4 billion in settlement to lawsuits over the toll of OxyContin
Associated Press·3M·ReliableThis source consistently reports facts with minimal bias, demonstrating high-quality journalism and accuracy.CenterThis outlet is balanced or reflects centrist views.
Summary
Purdue Pharma and the Sackler family have agreed to pay up to $7.4 billion to settle lawsuits related to the opioid crisis, significantly increasing their previous settlement by over $1 billion. The Sacklers will contribute $6.5 billion and Purdue $900 million. This deal aims to compensate victims and fund opioid addiction treatment, but requires court approval. The arrangement ends Sackler control over Purdue and restricts them from selling opioids in the U.S. Several state attorney generals participated in this negotiation, seeing it as a means to provide some closure to opioid crisis victims.
Perspectives
No center-leaning sources available for this story.
History
- 3M